Document is current
Any future updates will be listed below
-
Authors
Schulz, Jenna M.
Birmingham, Trevor B.
Philpott, Holly T.
Appleton, C. Thomas
Atkinson, Hayden F.
Giffin, J. Robert
Beier, Frank
- License Information
-
More Information
Article History
Received: 9 April 2024
Accepted: 29 September 2024
First Online: 10 October 2024
Declarations
:
: The study was approved by the Western Health Sciences Ethics Research Board (#1187). Written informed consent was obtained from all participants.
: Not applicable.
: CTA is a consultant for Abbvie, Amgen, Bristol Myers Squibb, Celgene, Fresenius Kabi, Gilead, Janssen, Merck, Novartis, Pfizer, Hoffmaan LaRoche, Sandoz, Sanofi-Genzyme, and UCB.
